News
Press Releases
-
May 8, 2024
The Clinical Trial Application for SGB-3908 for the Treatment of Hypertension Has Been Accepted by the China Center for Drug Evaluation
-
Feb 26, 2024
SGB-9768 (C3 siRNA) Has Been Approved for Phase 1 Clinical Trial Initiation in New Zealand
-
Dec 27, 2023
SanegeneBio and Innovent Enter Strategic Collaboration to Develop siRNA Drug for the Treatment of Hypertension